UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Trends in patient‐reported outcome use in early phase dose‐finding oncology trials – an analysis of ClinicalTrials.gov

Cancer medicine (Malden, MA), 2021-11, Vol.10 (22), p.7943-7957

2021

Volltextzugriff (PDF)

Changes in clinical trials of endocrine disorder and metabolism and nutrition disorder drugs in mainland China over 2010–2019

Pharmacology research & perspectives, 2021-04, Vol.9 (2), p.e00729-n/a

2021

Volltextzugriff (PDF)

Introduction of anti-TNF therapy has not yielded expected declines in hospitalisation and intestinal resection rates in inflammatory bowel diseases: a population-based interrupted time series study

Gut, 2020-02, Vol.69 (2), p.274-282

2020

Volltextzugriff (PDF)

Trends in GPCR drug discovery: new agents, targets and indications

Nature reviews. Drug discovery, 2017-12, Vol.16 (12), p.829-842

2017

Volltextzugriff (PDF)

A systematic analysis of FDA-approved anticancer drugs

BMC systems biology, 2017-10, Vol.11 (Suppl 5), p.87-87, Article 87

2017

Volltextzugriff (PDF)

Global trends in antimicrobial resistance in animals in low- and middle-income countries

Science (American Association for the Advancement of Science), 2019-09, Vol.365 (6459)

2019

Volltextzugriff (PDF)

Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

The Lancet (British edition), 2020-10, Vol.396 (10258), p.1223-1249

2020

Volltextzugriff (PDF)

Trends in peptide drug discovery

Nature reviews. Drug discovery, 2021-04, Vol.20 (4), p.309-325

2021

Volltextzugriff (PDF)

AMP-activated protein kinase: the current landscape for drug development

Nature reviews. Drug discovery, 2019-07, Vol.18 (7), p.527-551

2019

Volltextzugriff (PDF)

Pricing of pharmaceuticals is becoming a major challenge for health systems

BMJ (Online), 2020-01, Vol.368, p.l4627

2020

Volltextzugriff (PDF)

The decline of venture capital investment in early-stage life sciences poses a challenge to continued innovation

Health Affairs, 2015-02, Vol.34 (2), p.271-276

Fleming, Jonathan J

2015

Volltextzugriff (PDF)

Decline in economic returns from new drugs raises questions about sustaining innovations

Health Affairs, 2015-02, Vol.34 (2), p.245-252

2015

Volltextzugriff (PDF)

Risk to heroin users of polydrug use of pregabalin or gabapentin

Addiction (Abingdon, England), 2017-09, Vol.112 (9), p.1580-1589

2017

Volltextzugriff (PDF)

Using four decades of FDA orphan drug designations to describe trends in rare disease drug development: substantial growth seen in development of drugs for rare oncologic, neurologic, and pediatric-onset diseases

Orphanet journal of rare diseases, 2021-06, Vol.16 (1), p.1-265, Article 265

2021

Volltextzugriff (PDF)

Successful improvement of antibiotic prescribing at Primary Care in Andalusia following the implementation of an antimicrobial guide through multifaceted interventions: An interrupted time-series analysis

PloS one, 2020-05, Vol.15 (5), p.e0233062-e0233062

2020

Volltextzugriff (PDF)

Trends in the approval of cancer therapies by the FDA in the twenty-first century

Nature reviews. Drug discovery, 2023-08, Vol.22 (8), p.625-640

2023

Volltextzugriff (PDF)

Multidrug-resistant gonorrhea: A research and development roadmap to discover new medicines

PLoS medicine, 2017-07, Vol.14 (7), p.e1002366-e1002366

2017

Volltextzugriff (PDF)

Increased growth and germination success in plants following hydrogen sulfide administration

PloS one, 2013-04, Vol.8 (4), p.e62048

2013

Volltextzugriff (PDF)

Is the priority review voucher program stimulating new drug development for tropical diseases?

PLoS neglected tropical diseases, 2018-08, Vol.12 (8), p.e0006695-e0006695

2018

Volltextzugriff (PDF)

Poly-product drug use disparities in adolescents of lower socioeconomic status: Emerging trends in nicotine products, marijuana products, and prescription drugs

Behaviour research and therapy, 2019-04, Vol.115, p.103-110

2019

Volltextzugriff (PDF)

Effects of cadmium stress on growth and physiological characteristics of sassafras seedlings

Scientific reports, 2021-05, Vol.11 (1), p.9913-11, Article 9913

2021

Volltextzugriff (PDF)

Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis

The Lancet infectious diseases, 2019-02, Vol.19 (2), p.143-155

2019

Volltextzugriff (PDF)

Adolescent and adult time trends in US hallucinogen use, 2002–19: any use, and use of ecstasy, LSD and PCP

Addiction (Abingdon, England), 2022-12, Vol.117 (12), p.3099-3109

2022

Volltextzugriff (PDF)

Modeling the relationship between estimated fungicide use and disease-associated yield losses of soybean in the United States I: Foliar fungicides vs foliar diseases

PloS one, 2020-06, Vol.15 (6), p.e0234390

2020

Volltextzugriff (PDF)

Bloodstream infections in community hospitals in the 21st century: a multicenter cohort study

PloS one, 2014-03, Vol.9 (3), p.e91713-e91713

2014

Volltextzugriff (PDF)

1 – 25 von 3.493

Suche als RSS-Feed

Aktive Filter

ThemaTrends

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.314)
Mit Volltextzugriff
(1.504)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

R&d
(1.784)
Research & Development
(1.783)
Pharmaceutical Industry
(1.169)
Drugs
(1.162)
Science & Technology
(1.128)
Life Sciences & Biomedicine
(787)
Product Development
(745)
Humans
(621)
Pharmaceuticals
(541)
Drug Stores
(482)
Market Shares
(427)
Clinical Trials
(412)
Laboratories
(374)
Pharmacy
(347)
Patients
(346)
Prescription Drugs
(329)
Drug Dosages
(324)
Epidemiology
(322)
Science & Technology - Other Topics
(311)

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Trends in patient‐reported outcome use in early phase dose‐finding oncology trials – an analysis of ClinicalTrials.gov

Changes in clinical trials of endocrine disorder and metabolism and nutrition disorder drugs in mainland China over 2010–2019

Introduction of anti-TNF therapy has not yielded expected declines in hospitalisation and intestinal resection rates in inflammatory bowel diseases: a population-based interrupted time series study

Trends in GPCR drug discovery: new agents, targets and indications

A systematic analysis of FDA-approved anticancer drugs

Global trends in antimicrobial resistance in animals in low- and middle-income countries

Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

Trends in peptide drug discovery

AMP-activated protein kinase: the current landscape for drug development

Pricing of pharmaceuticals is becoming a major challenge for health systems

The decline of venture capital investment in early-stage life sciences poses a challenge to continued innovation

Decline in economic returns from new drugs raises questions about sustaining innovations

Risk to heroin users of polydrug use of pregabalin or gabapentin

Using four decades of FDA orphan drug designations to describe trends in rare disease drug development: substantial growth seen in development of drugs for rare oncologic, neurologic, and pediatric-onset diseases

Successful improvement of antibiotic prescribing at Primary Care in Andalusia following the implementation of an antimicrobial guide through multifaceted interventions: An interrupted time-series analysis

Trends in the approval of cancer therapies by the FDA in the twenty-first century

Multidrug-resistant gonorrhea: A research and development roadmap to discover new medicines

Increased growth and germination success in plants following hydrogen sulfide administration

Is the priority review voucher program stimulating new drug development for tropical diseases?

Poly-product drug use disparities in adolescents of lower socioeconomic status: Emerging trends in nicotine products, marijuana products, and prescription drugs

Effects of cadmium stress on growth and physiological characteristics of sassafras seedlings

Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis

Adolescent and adult time trends in US hallucinogen use, 2002–19: any use, and use of ecstasy, LSD and PCP

Modeling the relationship between estimated fungicide use and disease-associated yield losses of soybean in the United States I: Foliar fungicides vs foliar diseases

Bloodstream infections in community hospitals in the 21st century: a multicenter cohort study

Aktive Filter

Suchergebnisse filtern